Follow
Mingu Kang
Mingu Kang
Lunit
Verified email at lunit.io
Title
Cited by
Cited by
Year
Benchmarking self-supervised learning on diverse pathology datasets
M Kang, H Song, S Park, D Yoo, S Pereira
Proceedings of the IEEE/CVF Conference on Computer Vision and Pattern …, 2023
472023
Artificial intelligence (AI)–powered spatial analysis of tumor-infiltrating lymphocytes (TIL) for prediction of response to neoadjuvant chemotherapy (NAC) in triple-negative …
HJ Lee, SY Cho, EY Cho, Y Lim, SI Cho, W Jung, S Song, M Kang, J Ryu, ...
Journal of Clinical Oncology 40 (16_suppl), 595-595, 2022
42022
Applying tensor decomposition to image for robustness against adversarial attack
S Cho, TJ Jun, M Kang, D Kim
arXiv preprint arXiv:2002.12913, 2020
42020
Artificial intelligence-powered whole-slide image analyzer reveals a distinctive distribution of tumor-infiltrating lymphocytes in neuroendocrine neoplasms
HG Cho, SI Cho, S Choi, W Jung, J Shin, G Park, J Moon, M Ma, H Song, ...
Diagnostics 12 (10), 2340, 2022
32022
Rankingmatch: Delving into semi-supervised learning with consistency regularization and ranking loss
TQ Tran, M Kang, D Kim
arXiv preprint arXiv:2110.04430, 2021
32021
Resilience against Adversarial Examples: Data-Augmentation Exploiting Generative Adversarial Networks.
M Kang, HK Kim, S Lee, S Han
KSII Transactions on Internet & Information Systems 15 (11), 2021
22021
CAP-GAN: Towards adversarial robustness with cycle-consistent attentional purification
M Kang, TQ Tran, S Cho, D Kim
2021 International Joint Conference on Neural Networks (IJCNN), 1-8, 2021
22021
Correlation of fragmented pattern of tumor mass captured by artificial intelligence (AI)-powered whole-slide image (WSI) analysis with biased fibroblast expansion over tumor …
S Kim, S Song, G Park, S Kim, H Song, M Kang, S Pereira, CY Ock
Journal of Clinical Oncology 41 (16_suppl), e14657-e14657, 2023
12023
ReRankMatch: Semi-supervised learning with semantics-oriented similarity representation
TQ Tran, M Kang, D Kim
2021 International Joint Conference on Neural Networks (IJCNN), 1-8, 2021
12021
A phase II open-label randomized clinical trial of preoperative durvalumab or durvalumab plus tremelimumab in resectable head and neck squamous cell carcinoma
CG Kim, MH Hong, D Kim, BH Lee, H Kim, CY Ock, G Kelly, YJ Bang, ...
Clinical Cancer Research, OF1-OF14, 2024
2024
Artificial intelligence-powered analysis of tumor-stroma ratio and fibroblast density as prognostic indicators in colorectal cancer
M Jung, JY Kim, M Kang, J Lee, S Song, T Lee, W Jung, SI Cho
Cancer Research 84 (6_Supplement), 276-276, 2024
2024
Augmented interpretation of HER2, ER, and PR in breast cancer by artificial intelligence analyzer: enhancing interobserver agreement through a reader study of 201 cases
M Jung, SG Song, SI Cho, S Shin, T Lee, W Jung, H Lee, J Park, S Song, ...
Breast Cancer Research 26 (1), 31, 2024
2024
1293 Fragmented pattern of tumor mass is related to fibroblast activation mitigating spatial interaction between tumor and immune cells
S Kim, S Song, S Kim, M Kang, M Mostafavi, D Yoo, CH Ahn, S Ali, ...
Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023
2023
961 Tumor-infiltrating lymphocytes in tumor microenvironment assessed by artificial intelligence powered H&E image analyzer is correlated with immunomodulatory subtype of …
J Moon, CH Ahn, S Shin, S Kim, T Lee, SI Cho, Y Lim, M Kang, H Song, ...
Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023
2023
Dynamic change of immune phenotype assessed by artificial intelligence (AI)-powered analysis of tumor-infiltrating lymphocytes (TILs) during neoadjuvant durvalumab with or …
H Kim, YW Koh, HJ Hong, DH Kim, NS Sim, HR Kim, MH Hong, CG Kim, ...
Journal of Clinical Oncology 41 (16_suppl), 2578-2578, 2023
2023
Micron-resolution spatial analysis near the tumor-stromal border reveals a distinct density distribution of tumor-infiltrating lymphocytes and related genomic features
S Song, G Park, S Kim, S Choi, S Kim, W Jung, M Kang, M Mostafavi, ...
Cancer Research 83 (7_Supplement), 5389-5389, 2023
2023
Artificial intelligence (AI)-powered immune phenotyping to predict outcomes of immuno-oncology (IO)-based regimens in hepatocellular carcinoma (HCC).
H Chon, C Kim, B Kang, J Cheon, G Kim, C Oum, S Kim, G Park, ...
Journal of Clinical Oncology 41 (4_suppl), 601-601, 2023
2023
P1. 01-60 Prognostic Impact of PD-L1 Expression on EGFR Tyrosine Kinase Inhibition in Lung Adenocarcinoma
M Kang, SH Kim, SW Yoon, KJ Suh, YJ Kim, C Ock, M Kim, B Keam, ...
Journal of Thoracic Oncology 14 (10), S381-S382, 2019
2019
Benchmarking Self-Supervised Learning on Diverse Pathology Datasets (Supplementary Materials)
M Kang, H Song, SPDYS Pereira
The system can't perform the operation now. Try again later.
Articles 1–19